Dividend Seeker.
Fund holdings lookup
Request failed

As of the latest SEC filings, enGene Therapeutics Inc. (ENGN) is held by 12 institutional funds. The largest fund shareholder is Franklin Biotechnology Discovery Fund (FBTDX), holding an estimated $3,537,429.33 in market value, representing 0.34% of its portfolio.

Funds holding enGene Therapeutics Inc. (ENGN)

Source: SEC Form N-PORT institutional portfolio disclosures

Ticker:
ENGN
CIK:
0001980845
12 results
Fund Type Manager Weight Market Value Shares
Report Date
Filing Date
FBTDX
Franklin Biotechnology Discovery Fund
MF Franklin Templeton 0.34% $3,537,429.33 486,579 Apr 30, 2026 Jun 24, 2026
FBIOX
Select Biotechnology Portfolio
MF Fidelity 0.04% $2,347,542.00 232,200 Feb 28, 2026 Apr 24, 2026
FNCMX
Fidelity Nasdaq Composite Index Fund
MF Fidelity 0.00% $392,288.22 38,802 Feb 28, 2026 Apr 24, 2026
AVSC
Avantis U.S. Small Cap Equity ETF
ETF American Century 0.01% $329,232.15 32,565 Feb 28, 2026 Apr 29, 2026
BBC
Virtus Biotech Clinical Trials Etf
ETF Independent / Boutique 0.64% $237,183.75 32,625 Apr 30, 2026 Jun 22, 2026
NKMCX
NORTH SQUARE KENNEDY MICROCAP FUND
MF Independent / Boutique 0.38% $114,030.69 11,279 Feb 28, 2026 Apr 27, 2026
-
TIFF MULTI-ASSET FUND
ETF Independent / Boutique 0.01% $72,451.59 10,639 Mar 31, 2026 Jun 1, 2026
-
JNL/DFA U.S. Small Cap Fund
ETF Independent / Boutique 0.01% $67,922.94 9,974 Mar 31, 2026 May 28, 2026
NSGRX
Small Cap Core Fund
MF Independent / Boutique 0.02% $60,867.78 8,938 Mar 31, 2026 May 28, 2026
AVSBX
Avantis U.S. Small Cap Equity Fund
MF American Century 0.05% $59,669.22 5,902 Feb 28, 2026 Apr 29, 2026
AVUSX
Avantis U.S. Equity Fund
MF American Century 0.00% $11,373.75 1,125 Feb 28, 2026 Apr 29, 2026
-
AST Small-Cap Equity Portfolio
ETF Independent / Boutique 0.00% $9,370.56 1,376 Mar 31, 2026 May 27, 2026
Advertisement (320x50)